Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
54
IMRX Quote, Financials, Valuation and Earnings
Last price:
$4.31
Seasonality move
:
56.22%
Day range:
$3.82 - $4.17
52-week range:
$1.00 - $4.60
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
393.82x
P/B ratio:
3.41x
Volume:
637.7K
Avg. volume:
2.3M
1-year change:
216.8%
Market cap:
$142.5M
Revenue:
--
EPS (TTM):
-$1.96
Earnings Data
Next earnings date for IMRX
Aug 06
2025
Most recent earnings per share
-$0.42
Beat by $0.17
(May 5/2025)
Consensus Estimate
-$0.59
(May 5/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
IMRX Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | -- | -- | -- | -$0.44 | -- |
| 08/06/2025 | Q2 | -- | -- | -- | -$0.42 | -- |
| 05/05/2025 | Q1 | -- | -- | -$0.42 | -$0.59 | $0.17 |
| 03/20/2025 | Q4 | -- | -- | -$0.58 | -$0.45 | -$0.14 |
| 11/13/2024 | Q3 | -- | -- | -$0.49 | -$0.55 | $0.06 |
| 08/06/2024 | Q2 | -- | -- | -$0.47 | -$0.53 | $0.06 |
| 05/07/2024 | Q1 | -- | -- | -$0.49 | -$0.50 | $0.01 |
| 03/01/2024 | Q4 | -- | -- | -$0.52 | -$0.48 | -$0.04 |
| 11/09/2023 | Q3 | -- | -- | -$0.43 | -$0.49 | $0.06 |
| 08/03/2023 | Q2 | -- | -- | -$0.43 | -$0.53 | $0.10 |
| 05/04/2023 | Q1 | -- | -- | -$0.51 | -- | -- |
| 03/06/2023 | Q4 | -- | $460 | -$0.50 | -- | -- |
| 11/10/2022 | Q3 | -- | $38.4K | -$0.49 | -- | -- |
| 08/10/2022 | Q2 | -- | $94.4K | -$0.44 | -- | -- |
| 05/10/2022 | Q1 | -- | $183.7K | -$0.49 | -- | -- |
| 03/10/2022 | Q4 | -- | $189.6K | -$0.42 | -- | -- |
| 11/09/2021 | Q3 | -- | $482.1K | -$0.47 | -- | -- |
| 09/09/2021 | Q2 | -- | $660K | -$0.33 | -- | -- |
| 03/31/2021 | Q1 | -- | $748.2K | -$0.46 | -- | -- |
| 12/31/2020 | Q4 | -- | $665.1K | -$0.43 | -- | -- |
| 09/30/2020 | Q3 | -- | $682.6K | -$0.33 | -- | -- |
| 06/30/2020 | Q2 | -- | $480.8K | -$0.27 | -- | -- |
| 03/31/2020 | Q1 | -- | $483.1K | -$0.24 | -- | -- |
Immuneering Earnings Questions
-
How Much did Immuneering Generate in Revenue Last Quarter?
Immuneering reported -- worth of top line sales in its most recent quarter.
-
Did Immuneering Beat Earnings Last Quarter?
Immuneering announced earnings per share of -$0.42 which represents a beat of analyst forecast a -$0.59 per share.
-
Is Immuneering Profitable?
Immuneering reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Immuneering EPS Next Year?
Immuneering's earnings are forecast to decrease from -$2.04 per share to -$1.82 per share next year representing a decrease of -21.45%.
-
When is Immuneering's Earnings Date?
Immuneering's next earnings date is August 6, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
